SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 228 filers reported holding SAGE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $909,367 | -32.4% | 19,340 | -53.6% | 0.03% | -30.6% |
| Q2 2022 | $1,346,000 | +377.3% | 41,684 | +388.7% | 0.05% | +345.5% |
| Q1 2022 | $282,000 | -72.6% | 8,530 | -52.9% | 0.01% | -83.3% |
| Q2 2021 | $1,028,000 | +391.9% | 18,094 | +259.9% | 0.07% | +500.0% |
| Q2 2020 | $209,000 | -36.5% | 5,028 | -56.1% | 0.01% | -54.2% |
| Q1 2020 | $329,000 | -68.2% | 11,452 | -20.1% | 0.02% | -46.7% |
| Q4 2019 | $1,034,000 | +370.0% | 14,326 | +1092.8% | 0.04% | +275.0% |
| Q2 2019 | $220,000 | -32.9% | 1,201 | -88.3% | 0.01% | -53.8% |
| Q1 2016 | $328,000 | +54.0% | 10,234 | +103.4% | 0.03% | +44.4% |
| Q3 2015 | $213,000 | – | 5,031 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |